Renal Replacement Therapy News and Research

RSS

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Otsuka Pharmaceutical Europe Ltd. today announced that the European Commission has approved an extension of indication for JINARC to include adult patients with CKD stage 4 Autosomal Dominant Polycystic Kidney Disease

2 Aug 2018

Data-driven tool defines risk stages for children with chronic kidney disease

Experts in pediatric kidney disease have published a new staging system to help doctors better predict the length of time until a child with chronic kidney disease (CKD) will need to undergo a kidney transplant or start receiving dialysis. Although this type of prognostic guide exists for adults, this is the first such tool specific to children.

10 Apr 2018

Study reveals negative effect of hemodialysis on the brain of elderly patients

A new study reveals that hemodialysis may reduce blood flow to the brain in older patients being treated for kidney failure.

2 Mar 2018

Debate sessions at Acute Cardiovascular Care 2018 to focus on treatment for heart attack patients

The optimal treatment for heart attack patients will be debated at Acute Cardiovascular Care 2018. The annual congress of the Acute Cardiovascular Care Association, a registered branch of the European Society of Cardiology, will be held 3 to 5 March at the MiCo Milano Congressi in Milan, Italy.

5 Feb 2018

Kidney failure linked to lower quality of life, psychosocial challenges in young adults

Kidney failure is associated with lower quality of life in young people and limited employment, independence, and relationships compared with healthy peers, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology

20 Oct 2017

Intensive Care Medicine

Intensive care medicine is a young specialty that deals with the medical treatment of the sickest patients in the hospital. Intensive care medicine doctors are called intensivists and are expert physicians with special skills in the management of organ failure.

29 Aug 2017

Researchers reveal stark increase in opioid-related ICU admissions and deaths

Since 2009, hospital intensive care units have witnessed a stark increase in opioid-related admissions and deaths, according to new study led by researchers at Beth Israel Deaconess Medical Center's Center for Healthcare Delivery Science.

14 Aug 2017

Prevalence of atrial fibrillation in haemodialysis patients higher than previously thought

Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.

16 Jan 2017

Children's access to kidney transplantation is marred by racial disparities

Researchers have uncovered a higher risk of death in black vs. white children with kidney failure over the last two decades that seems to be mediated by differences in access to kidney transplantation.

30 Dec 2016

Higher proportion of CKD patients receive renal replacement therapy in the U.S. than other countries

A new study indicates that a much higher proportion of patients with advanced chronic kidney disease (CKD)—even those ≥85 years of age—receive renal replacement therapy (RRT) such as maintenance dialysis or kidney transplantation in the United States than in other developed countries.

23 Sep 2016

Empagliflozin offers long-term renal protection in Type 2 diabetes

The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.

16 Jun 2016

MERS individuals develop severe critical illness, higher mortality than non-MERS SARI patients

Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS.

19 May 2016

Study: Conservative care could be a reasonable choice for selected kidney failure patients

A new study found no significant survival advantage among elderly kidney failure patients who chose dialysis over conservative management. The findings, which appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology, indicate that conservative care may be a reasonable choice for selected older patients.

18 Mar 2016

MemorialCare partners with Fresenius Medical Care to operate 15 dialysis clinics in Southern California

MemorialCare Health System announced today that it has entered into a joint venture partnership with Fresenius Medical Care North America to operate 15 dialysis clinics in Orange and Los Angeles counties. Thirteen of these clinics are fully operational and two additional clinics are being developed in San Juan Capistrano and Huntington Beach.

17 Feb 2016

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

NxStage Medical, Inc., a leading manufacturer of dialysis products, today announced that the NxStage System One is now used in eight of the Top 10 Nephrology Hospitals in the United States as ranked according to U.S. News & World Report.

12 Aug 2015

Patient survival rates for home hemodialysis significantly higher than peritoneal dialysis

NxStage Medical, Inc. is encouraging patients to take control of their dialysis therapy and consider home hemodialysis in the wake of a new study that found patient survivability rates are significantly higher with home hemodialysis (HHD) than peritoneal dialysis (PD).

18 Jun 2015

Astute Medical's NephroCheck Test obtains measurements of two biomarkers that act as alarm for AKI risk

An intervention known as remote ischemic preconditioning (RIPC) significantly reduced the occurrence of acute kidney injury (AKI) in cardiac surgery patients and confirmed that post-operative elevations of two kidney biomarkers act as an alarm for risk of AKI, according to a study published online today in the Journal of the American Medical Association.

30 May 2015

First European approval of drug to treat genetic kidney disease ADPKD

Otsuka Pharmaceutical Co., Ltd. announced that the European Commission has granted marketing authorisation for JINARC® (tolvaptan) for the treatment of ADPKD in adults who have chronic kidney disease (CKD) stage one to three at initiation of treatment with evidence of rapidly progressing disease

29 May 2015

Lancet study: Most people lack access to life-saving treatments for kidney failure

New estimates published in The Lancet indicate that at best only half of people worldwide needing kidney dialysis or transplantation to treat kidney failure in 2010 received it. This suggests that at least 2.3 million people may have died prematurely from kidney failure because they could not access this life-saving treatment.

17 Mar 2015